Trichinella spiralis-induced mastocytosis and erythropoiesis are simultaneously supported by a bipotent mast cell/erythrocyte precursor cell
Open Access
- 18 May 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 16 (5) , e1008579
Abstract
Anti-helminth responses require robust type 2 cytokine production that simultaneously promotes worm expulsion and initiates the resolution of helminth-induced wounds and hemorrhaging. However, how infection-induced changes in hematopoiesis contribute to these seemingly distinct processes remains unknown. Recent studies have suggested the existence of a hematopoietic progenitor with dual mast cell-erythrocyte potential. Nonetheless, whether and how these progenitors contribute to host protection during an active infection remains to be defined. Here, we employed single cell RNA-sequencing and identified that the metabolic enzyme, carbonic anhydrase 1 (Car1) marks a predefined bone marrow-resident hematopoietic progenitor cell (HPC) population. Next, we generated a Car1-reporter mouse model and found that Car1-GFP positive progenitors represent bipotent mast cell/erythrocyte precursors. Finally, we show that Car1-expressing HPCs simultaneously support mast cell and erythrocyte responses during Trichinella spiralis infection. Collectively, these data suggest that mast cell/erythrocyte precursors are mobilized to promote type 2 cytokine responses and alleviate helminth-induced blood loss, developmentally linking these processes. Collectively, these studies reveal unappreciated hematopoietic events initiated by the host to combat helminth parasites and provide insight into the evolutionary pressure that may have shaped the developmental relationship between mast cells and erythrocytes. Helminth parasites infect approximately 2 billion people and represent a significant public health concern. Helminths undertake complex developmental life cycles through multiple organs and as a result cause substantial tissue damage. To combat this, mammals have evolved mechanisms to initiate balanced immune responses that promote inflammation needed to seclude parasites in granulomas, reduce parasitic burdens and mitigate the consequences of helminth-induced wounds. Despite their clinical importance, the mechanisms that regulate these events remain poorly defined. Here we have uncovered a unique progenitor cell that supports both proinflammatory mast cell responses and red blood cell development, thereby simultaneously initiating both of these host-protective responses. Collectively, these studies reveal unappreciated events initiated by the host to combat pathogens that infection billions of individuals worldwide.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (RO1 AI123224)
- National Institute of Allergy and Infectious Diseases (RO1 AI131634)
- Foundation for the National Institutes of Health (T32AI125185)
- Foundation for the National Institutes of Health (R01 AI131634-02S1)
This publication has 41 references indexed in Scilit:
- Alterations in Bone and Erythropoiesis in Hemolytic Anemia: Comparative Study in Bled, Phenylhydrazine-Treated and Plasmodium-Infected MicePLOS ONE, 2012
- Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl miceBlood, 2011
- Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive PathogensPLOS Pathogens, 2011
- Genetic analysis of basophil function in vivoNature Immunology, 2011
- IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responsesNature, 2010
- Isolation of Mouse Peritoneal Cavity CellsJournal of Visualized Experiments, 2010
- Hemoglobin research and the origins of molecular medicineBlood, 2008
- Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substratesBioorganic & Medicinal Chemistry Letters, 2008
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- MastocytosisJournal of Allergy and Clinical Immunology, 1984